Organon To Present at the 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Organon (NYSE: OGN) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. CEO Kevin Ali and CFO Matthew Walsh will engage in a fireside chat scheduled for Monday, January 13th, 2025, at 3:45 p.m. PT. The event will be accessible to investors, analysts, media representatives, and the general public through a live audio webcast, which can be accessed via the provided conference link.

JERSEY CITY, N.J.--(BUSINESS WIRE)-- Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at the 43^rd Annual J.P. Morgan Healthcare Conference on Monday, January 13th, 2025, at 3:45 p.m. PT.

Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation at:

https://jpmorgan.metameetings.net/events/healthcare25/sessions/58328-organon/webcast?gpu_only=true&kiosk=true

About Organon

Organon is an independent global healthcare company with a mission to help improve the health of women throughout their lives. Organon’s diverse portfolio offers more than 60 medicines and products in women’s health, biosimilars, and a large franchise of established medicines across a range of therapeutic areas. In addition to Organon’s current products, the company invests in innovative solutions and research to drive future growth opportunities in women’s health and biosimilars. Organon is also pursuing opportunities to collaborate with biopharmaceutical partners and innovators who look to commercialize their products by leveraging Organon’s scale and agile presence in fast growing international markets.

Organon has geographic scope with significant reach, world-class commercial capabilities, and approximately 10,000 employees with headquarters located in Jersey City, New Jersey.

For more information, visit http://www.organon.com and connect with us on LinkedIn, Instagram, X (formerly known as Twitter) and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241219194708/en/

Media Contacts:

Karissa Peer

(614) 314-8094

Kate Vossen

(732) 675-8448

Investor Contacts:

Jennifer Halchak

(201) 275-2711

Source: Organon & Co.

FAQ

When is Organon (OGN) presenting at the J.P. Morgan Healthcare Conference 2025?

Organon (OGN) is scheduled to present at the J.P. Morgan Healthcare Conference on Monday, January 13th, 2025, at 3:45 p.m. Pacific Time.

Who will represent Organon (OGN) at the 2025 J.P. Morgan Healthcare Conference?

Organon will be represented by CEO Kevin Ali and CFO Matthew Walsh in a fireside chat format.

Can the public access Organon's (OGN) presentation at the J.P. Morgan Healthcare Conference?

Yes, the public can access Organon's presentation through a live audio webcast available on the conference website.

What type of presentation format will Organon (OGN) use at the J.P. Morgan Healthcare Conference?

Organon will participate in a fireside chat format presentation at the conference.